Patients with cardiac amyloidosis have very poor survival without therapy. Diagnosis at early stages of the disease is crucial and there are many diagnostic tools for cardiac amyloidosis.

[Ash 2020;5b] Cardiac involvement with amyloid should be part of the differential diagnosis when 2D and Doppler echocardiographic findings are consistent with HF with preserved or borderline left ...

A common cause of this type of cardiac amyloidosis is having a diagnosis of certain blood cancers, like multiple myeloma.

More information: Clemens P Spielvogel et al, Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective ...

As cardiac amyloidosis has high morbidity and mortality, early diagnosis is crucial. With effective FDA-approved treatments now available, a scan that can definitively detect amyloidosis or ...

Definite diagnosis is based on endomyocardial biopsy and treatment of cardiac amyloidosis is a challenge. Heart transplantation, although controversial, has demonstrated survival benefit.

for PET imaging in patients with suspected or known cardiac amyloidosis. 124 I-evuzamitide has been granted orphan drug designations as a diagnostic for the management of ATTR and AL amyloidosis ...

As cardiac amyloidosis has high morbidity and mortality, early diagnosis is crucial. With effective FDA-approved treatments now available, a scan that can definitively detect amyloidosis or exclude it ...